Therapy Area Explorer

Breaks the market down by disease area (cardiac, diabetes, CNS, oncology…) — how big each is, how fast it's growing, and how much pricing power companies have there.

Each card is one therapy area, sorted by growth. Violet-ringed cards are areas where Rubicon's pipeline is active. Use it to see which disease categories are most attractive to compete in.

Chronicity

— Whether the illness is chronic (long-term, recurring revenue) or acute (one-off treatment).

Pricing power

— How freely companies can price — limited where NLEM price controls apply.

CNS

— Central Nervous System — neurology/psychiatry drugs (ADHD, migraine, etc.), a Rubicon focus.